Spots Global Cancer Trial Database for recurrent endometrial carcinoma

Every month we try and update this database with for recurrent endometrial carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer	NCT00003946	Endometrial Can...	danazol	-	GOG Foundation
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	NCT04781088	Platinum-Resist... Platinum-Resist... Platinum-Resist... Recurrent Endom... Recurrent Fallo... Recurrent Ovari... Recurrent Prima...	Lenvatinib Paclitaxel Pembrolizumab	18 Years -	Ohio State University Comprehensive Cancer Center
Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer	NCT03586661	Deleterious BRC... Deleterious BRC... Endometrial Ade... High Grade Ovar... Platinum-Resist... Primary Periton... Progressive Dis... Recurrent Endom... Recurrent Fallo... Recurrent Ovari... Recurrent Prima...	Copanlisib Niraparib	18 Years -	M.D. Anderson Cancer Center
Endometrial Cancer Recurrence in Patients Taking Metformin	NCT05192850	Recurrent Endom...	Metformin use	18 Years - 99 Years	WellSpan Health
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer	NCT00003135	Breast Cancer Cervical Cancer Endometrial Can... Ovarian Cancer	fluorouracil pegylated lipos... hyperthermia tr...	18 Years -	National Cancer Institute (NCI)
Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers	NCT03924245	Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... High Grade Fall... High Grade Ovar... Ovarian Carcino... Ovarian Clear C... Ovarian Endomet... Primary Periton... Recurrent Endom... Recurrent Ovari... Recurrent Prima...	Entinostat Olaparib	18 Years -	Vanderbilt-Ingram Cancer Center
Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer	NCT00258362	Endometrial Can...	carboplatin docetaxel radiation thera...	18 Years -	Masonic Cancer Center, University of Minnesota
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer	NCT00287885	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... Sarcoma Vaginal Cancer Vulvar Cancer	docetaxel	18 Years -	Masonic Cancer Center, University of Minnesota
Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer	NCT03367741	Advanced Endome... Metastatic Endo... Recurrent Endom... Stage III Uteri... Stage IV Uterin...	Biopsy Biospecimen Col... Cabozantinib S-... Computed Tomogr... Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma	NCT00082823	Cancer	ziv-aflibercept	18 Years - 120 Years	Regeneron Pharmaceuticals
Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290	NCT02093546	Recurrent Endom...	Biospecimen Col...	18 Years -	M.D. Anderson Cancer Center
Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer	NCT00003439	Cancer	recombinant int...	18 Years -	National Cancer Institute (NCI)
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity	NCT00003548	Cancer	aminocamptothec...	18 Years -	NYU Langone Health
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer	NCT00245050	Breast Cancer Drug/Agent Toxi... Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi...	pyridoxine hydr... Placebo doxorubicin HCL...	-	Case Comprehensive Cancer Center
Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer	NCT00005861	Endometrial Can...	pegylated lipos...	-	GOG Foundation
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma	NCT05112601	Endometrial Ade... Endometrial Cle... Endometrial Ded... Endometrial End... Endometrial Mix... Endometrial Muc... Endometrial Und... Endometrioid Ad... Recurrent Endom...	Biospecimen Col... Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer	NCT00030485	Endometrial Can...	erlotinib hydro...	18 Years -	National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT00023894	Endometrial Can...	alvocidib	-	National Cancer Institute (NCI)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial	NCT05564377	Advanced Malign... Anatomic Stage ... Anatomic Stage ... Locally Advance... Malignant Femal... Metastatic HER2... Metastatic Mali... Recurrent Endom... Recurrent Fallo... Recurrent Malig... Recurrent Malig... Recurrent Ovari... Recurrent Prima... Unresectable HE... Unresectable Ma...	Alpelisib Binimetinib Biopsy Biospecimen Col... Bone Marrow Asp... Bone Scan Computed Tomogr... Echocardiograph... Fluorouracil Fulvestrant Ipatasertib Leucovorin Magnetic Resona... Multigated Acqu... Mutation Carrie... Neratinib Malea... Nilotinib Hydro... Olaparib Oxaliplatin Paclitaxel Palbociclib Panitumumab Positron Emissi... Selumetinib Sul... Sotorasib	-	National Cancer Institute (NCI)
Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer	NCT00071929	Endometrial Can...	oxaliplatin	18 Years -	National Cancer Institute (NCI)
CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer	NCT00610740	Cervical Cancer Endometrial Can... Ovarian Cancer	topical gemcita... therapeutic con...	18 Years -	Masonic Cancer Center, University of Minnesota
Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer	NCT00118300	Cervical Cancer Endometrial Can... Ovarian Cancer Vaginal Cancer	capecitabine brachytherapy radiation thera...	18 Years -	Case Comprehensive Cancer Center
A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma	NCT03008408	Recurrent Endom... Recurrent Endom... Refractory Endo... Refractory Endo... Stage III Uteri... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IIIC1 Ute... Stage IIIC2 Ute... Stage IV Uterin... Stage IVA Uteri... Stage IVB Uteri...	Everolimus Letrozole Ribociclib	18 Years -	M.D. Anderson Cancer Center
Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer	NCT00770185	Endometrial Can...	ridaforolimus gene expression... immunohistochem... laboratory biom...	18 Years -	Canadian Cancer Trials Group
Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers	NCT05691504	Advanced Endome... Metastatic Endo... Metastatic Fall... Metastatic Plat... Metastatic Prim... Recurrent Endom... Recurrent Fallo... Recurrent Plati... Recurrent Prima... Stage III Uteri... Stage IV Uterin...	Biopsy Biospecimen Col... Cobimetinib Computed Tomogr... Echocardiograph... Magnetic Resona... Multigated Acqu... Pelcitoclax	18 Years -	National Cancer Institute (NCI)
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer	NCT01764789	Anxiety Disorde... Depression Fatigue Leydig Cell Tum... Ovarian Sarcoma Ovarian Stromal... Pain Peritoneal Carc... Pseudomyxoma Pe... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Fallo... Recurrent Gesta... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Recurrent Vagin... Recurrent Vulva...	questionnaire a... quality-of-life... psychosocial as... behavioral inte... cognitive inter... educational int...	21 Years - 85 Years	Ohio State University Comprehensive Cancer Center
Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma	NCT05603910	Recurrent Endom... Unresectable En...	Lenvatinib Pembrolizumab Hypofractionate...	18 Years -	University of Miami
S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer	NCT00003127	Endometrial Can...	amifostine trih... carboplatin paclitaxel	16 Years -	SWOG Cancer Research Network
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial	NCT05554328	Recurrent Endom... Recurrent Fallo... Recurrent Ovari... Recurrent Prima...	Biopsy Biospecimen Col... Bone Marrow Asp... Computed Tomogr... Echocardiograph... Multigated Acqu... Olaparib Selumetinib Sul...	18 Years -	National Cancer Institute (NCI)
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer	NCT00003704	Cancer	capecitabine radiation thera...	18 Years -	Alliance for Clinical Trials in Oncology
Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer	NCT00005031	Endometrial Can...	irofulven	18 Years -	GOG Foundation
Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)	NCT00085332	Endometrial Can...	docetaxel	-	GOG Foundation
Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer	NCT01943058	Atypical Endome... Endometrial Ade... Recurrent Endom... Stage IA Endome... Stage IB Endome... Stage II Endome... Stage IIIA Endo... Stage IIIB Endo... Stage IIIC Endo... Stage IVA Endom... Stage IVB Endom...	megestrol aceta... levonorgestrel-... laboratory biom... questionnaire a...	18 Years - 44 Years	University of Southern California
Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer	NCT00016341	Endometrial Can...	filgrastim cisplatin doxorubicin hyd... megestrol aceta... paclitaxel tamoxifen citra...	-	GOG Foundation
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract	NCT00003334	Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma	paclitaxel pegylated lipos...	- 120 Years	NYU Langone Health
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma	NCT00101972	Cancer	monoclonal anti...	18 Years -	MacroGenics
Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer	NCT00470067	Endometrial Can...	carboplatin pegylated lipos...	18 Years -	Roswell Park Cancer Institute
Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer	NCT00004915	Endometrial Can...	raloxifene	18 Years -	Northwestern University
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers	NCT03968406	Malignant Femal... Recurrent Cervi... Recurrent Endom... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Recurrent Vagin... Stage IV Cervic... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IV Uterin... Stage IV Vagina... Stage IVA Cervi... Stage IVA Fallo... Stage IVA Ovari... Stage IVA Prima... Stage IVA Uteri... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Fallo... Stage IVB Ovari... Stage IVB Prima... Stage IVB Uteri... Stage IVB Vagin...	Quality-of-Life... Radiation Thera... Talazoparib	18 Years -	M.D. Anderson Cancer Center
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer	NCT00032162	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma	carboplatin pegylated lipos...	18 Years -	AGO Study Group
Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290	NCT02093546	Recurrent Endom...	Biospecimen Col...	18 Years -	M.D. Anderson Cancer Center
Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer	NCT00071929	Endometrial Can...	oxaliplatin	18 Years -	National Cancer Institute (NCI)
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors	NCT00019331	Colorectal Canc... Endometrial Can... Head and Neck C... Liver Cancer Lung Cancer Melanoma (Skin) Pancreatic Canc... Testicular Germ... Unspecified Adu...	aldesleukin ras peptide can... sargramostim DetoxPC	18 Years -	National Cancer Institute (NCI)
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma	NCT05112601	Endometrial Ade... Endometrial Cle... Endometrial Ded... Endometrial End... Endometrial Mix... Endometrial Muc... Endometrial Und... Endometrioid Ad... Recurrent Endom...	Biospecimen Col... Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer	NCT00022620	Endometrial Can...	paclitaxel	- 75 Years	European Organisation for Research and Treatment of Cancer - EORTC
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer	NCT00003135	Breast Cancer Cervical Cancer Endometrial Can... Ovarian Cancer	fluorouracil pegylated lipos... hyperthermia tr...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer	NCT00016341	Endometrial Can...	filgrastim cisplatin doxorubicin hyd... megestrol aceta... paclitaxel tamoxifen citra...	-	GOG Foundation
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma	NCT00002465	Breast Cancer Endometrial Can... Malignant Mesot...	megestrol aceta...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer	NCT00003691	Endometrial Can...	filgrastim cisplatin doxorubicin hyd... paclitaxel	18 Years -	GOG Foundation
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract	NCT00003334	Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma	paclitaxel pegylated lipos...	- 120 Years	NYU Langone Health
Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT00025467	Endometrial Ade... Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Pap... Recurrent Endom...	thalidomide laboratory biom...	-	National Cancer Institute (NCI)
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma	NCT00083213	Cancer	ziv-aflibercept	18 Years - 120 Years	Regeneron Pharmaceuticals
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer	NCT00245050	Breast Cancer Drug/Agent Toxi... Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi...	pyridoxine hydr... Placebo doxorubicin HCL...	-	Case Comprehensive Cancer Center
VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT00462826	Recurrent Endom...	ziv-aflibercept	18 Years -	National Cancer Institute (NCI)
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial	NCT05554328	Recurrent Endom... Recurrent Fallo... Recurrent Ovari... Recurrent Prima...	Biopsy Biospecimen Col... Bone Marrow Asp... Computed Tomogr... Echocardiograph... Multigated Acqu... Olaparib Selumetinib Sul...	18 Years -	National Cancer Institute (NCI)
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer	NCT04469764	Recurrent Endom... Recurrent Fallo... Recurrent Ovari... Recurrent Prima...	Abemaciclib Anastrozole Letrozole	-	Jonsson Comprehensive Cancer Center
Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer	NCT00087100	Endometrial Can...	pemetrexed diso...	-	GOG Foundation
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer	NCT03914612	Endometrial Cle... Endometrial Ded... Endometrial End... Endometrial Mix... Endometrial Ser... Endometrial Und... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Stage III Uteri... Stage IV Uterin...	Carboplatin Computed Tomogr... Paclitaxel Pembrolizumab Placebo Adminis... Quality-of-Life... Questionnaire A...	18 Years -	National Cancer Institute (NCI)
Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290	NCT02093546	Recurrent Endom...	Biospecimen Col...	18 Years -	M.D. Anderson Cancer Center
Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer	NCT01943058	Atypical Endome... Endometrial Ade... Recurrent Endom... Stage IA Endome... Stage IB Endome... Stage II Endome... Stage IIIA Endo... Stage IIIB Endo... Stage IIIC Endo... Stage IVA Endom... Stage IVB Endom...	megestrol aceta... levonorgestrel-... laboratory biom... questionnaire a...	18 Years - 44 Years	University of Southern California
Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer	NCT00072176	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Pap... Recurrent Endom... Stage IIIA Endo... Stage IIIB Endo... Stage IIIC Endo... Stage IVA Endom... Stage IVB Endom...	temsirolimus laboratory biom...	18 Years -	National Cancer Institute (NCI)
Endometrial Cancer Recurrence in Patients Taking Metformin	NCT05192850	Recurrent Endom...	Metformin use	18 Years - 99 Years	WellSpan Health
Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT00096447	Recurrent Endom...	lapatinib ditos...	18 Years -	National Cancer Institute (NCI)
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer	NCT00003704	Cancer	capecitabine radiation thera...	18 Years -	Alliance for Clinical Trials in Oncology
Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer	NCT04906382	Lynch Syndrome Recurrent Endom... Recurrent Endom... Recurrent Uteri... Mismatch Repair... Recurrent Endom... Metastatic Endo...	Biopsy Carboplatin Paclitaxel Tislelizumab	18 Years -	Ohio State University Comprehensive Cancer Center
CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer	NCT00610740	Cervical Cancer Endometrial Can... Ovarian Cancer	topical gemcita... therapeutic con...	18 Years -	Masonic Cancer Center, University of Minnesota
Everolimus in Treating Patients With Relapsed or Metastatic Endometrial Cancer	NCT00870337	Endometrial Can...	everolimus	18 Years -	ARCAGY/ GINECO GROUP
Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis	NCT03508570	Malignant Perit... Malignant Retro... Metastatic Cerv... Metastatic Endo... Metastatic Fall... Metastatic Mali... Metastatic Ovar... Metastatic Prim... Peritoneal Carc... Platinum-Refrac... Platinum-Refrac... Platinum-Refrac... Platinum-Refrac... Platinum-Resist... Platinum-Resist... Platinum-Resist... Platinum-Resist... Recurrent Cervi... Recurrent Endom... Recurrent Fallo... Recurrent Malig... Recurrent Ovari... Recurrent Prima... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IVA Fallo... Stage IVA Ovari... Stage IVA Prima... Stage IVB Cervi... Stage IVB Fallo... Stage IVB Ovari... Stage IVB Prima... Stage IVB Uteri...	Ipilimumab Laboratory Biom... Nivolumab Pharmacokinetic...	18 Years -	M.D. Anderson Cancer Center
Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation	NCT05523440	Recurrent Endom... Recurrent Ovari... ARID1A Gene Mut...	Bevacizumab Niraparib	18 Years -	University of Oklahoma
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer	NCT00003439	Cancer	recombinant int...	18 Years -	National Cancer Institute (NCI)
Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer	NCT00006377	Endometrial Can...	carboplatin doxorubicin hyd... paclitaxel	18 Years -	Memorial Sloan Kettering Cancer Center
Gene Therapy in Treating Patients With Cancer	NCT00004178	Cancer	therapeutic aut...	18 Years -	Roger Williams Medical Center
Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer	NCT00005861	Endometrial Can...	pegylated lipos...	-	GOG Foundation

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: